Format

Send to

Choose Destination
Biomed Res Int. 2013;2013:435268. doi: 10.1155/2013/435268. Epub 2013 Aug 7.

Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility.

Author information

1
Department of Internal Medicine, Gastroenterology Division, Catholic University of Sacred Hearth, Policlinico "A. Gemelli" Hospital, lgo Gemelli 8, 00168 Roma, Italy. francoscaldaferri@libero.it

Abstract

Inflammatory bowel diseases are chronic diseases affecting the gastrointestinal tract, whose major forms are represented by Crohn's disease (CD) and ulcerative colitis (UC). Their etiology is still unclear, although several factors have been identified as major determinants for induction or relapses. Among these, the role of the "forgotten organ", gut microbiota, has become more appreciated in recent years. The delicate symbiotic relationship between the gut microbiota and the host appears to be lost in IBD. In this perspective, several studies have been conducted to assess the role of prebiotics and probiotics in gut microbiota modulation. This is a minireview aimed to address in an easy format (simple questions-simple answers) some common issues about the theme. An update on the role of selected constituents of gut microbiota in the pathogenesis of IBD is presented together with the analysis of the efficacy of gut microbiota modulation by prebiotics and probiotics administration in the management of IBD.

PMID:
23991417
PMCID:
PMC3749555
DOI:
10.1155/2013/435268
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Publishing Corporation Icon for PubMed Central
Loading ...
Support Center